← All diseases Blood and bone marrow

Myelodysplastic syndrome

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (47)Meta-analysis (14)Treatment guideline (3)Systematic review (10)Randomized trial (10)Phase 3 study (10)Clinical trial (605)Review article (239)Early study (phase 1 or 2) (47)Description of individual patients (223)Laboratory or animal studies (12)Commentary or editorial (67) Only studies currently recruiting participants (42)

Filter

Publications and studies (1773)

• The clinical, molecular, and prognostic features of the 2022 WHO and ICC classification systems for myelodysplastic neoplasms. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. VEXAS syndrome in a patient with DDX41 germline predisposition syndrome. (2024/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment. (2024/01/01) ♡
• Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11. (2024/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). (2024/01/01) ♡
• ABIN1 (Q478) is Required to Prevent Hematopoietic Deficiencies through Regulating Type I IFNs Expression. (2024/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape. (2024/01/01) ♡
• An MDS Patient with Deletion 20q and a t(9;22)(q34;q11.2): A Case Report and Review of the Literature. (2024/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Step-by-step endovascular repair for thoracoabdominal aortic aneurysm]. (2024/01/01) ♡
• Effects of Black Raspberry Supplementation on Methylation Pathways in Vav-creAsxl1(fl/fl)Tet2(fl/fl) Double Knockout Mice with Early-stage Myelodysplastic Syndrome. (2023/12/30) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells. (2023/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report of a patient with VEXAS syndrome. (2023/12/29) ♡
• Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice. (2023/12/28) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Introduction to a review series on myelodysplastic syndromes in the age of genomic medicine. (2023/12/28) ♡
• Telehealth serious illness care program for older adults with hematologic malignancies: a single-arm pilot study. (2023/12/26) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome. (2023/12/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AI-assisted proofreading of RNA splicing. (2023/12/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrating AI and ML in Myelodysplastic Syndrome Diagnosis: State-of-the-Art and Future Prospects. (2023/12/22) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M. (2023/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Normocytic anaemia due to multiple causes]. (2023/12/20) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Meta-analysis of decitabine pretreatment-based allogeneic hematopoietic stem cell transplantation affecting transplantation-related complications and prognosis in patients with malignant hematological disease. (2023/12/20) ♡
• Sweet Syndrome: Clinical Presentation, Malignancy Association, Autoinflammatory Disorders and Treatment Response in a Cohort of 93 Patients with Long-term Follow-up. (2023/12/19) ♡
• NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy. (2023/12/19) ♡
• 5-Aza-4'-thio-2'-deoxycytidine induces C>G transversions in a specific trinucleotide context and leads to acute lymphoid leukemia. (2023/12/19) ♡
• Erythroblastic islands: A fertile ground for CD47 expression in myelodysplastic syndrome and acute erythroid leukaemia. (2023/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review. (2023/12/18) ♡
• The future of myelodysplastic syndrome-patient priorities and outcomes that matter. (2023/12/18) ♡
• Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System. (2023/12/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential. (2023/12/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Danazol for the Treatment of Myelodysplastic Syndromes: A Systematic Review. (2023/12/14) ♡
• Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms. (2023/12/13) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Unusual Case of Hypercalcemia Due to Graft-Versus-Host Disease. (2023/12/13) ♡
• Discovery of U2AF1 neoantigens in myeloid neoplasms. (2023/12/12) ♡
• Frontline treatment options for higher-risk MDS: can we move past azacitidine? (2023/12/08) ♡
• Posttransplant complications in patients with marrow failure syndromes: are we improving long-term outcomes? (2023/12/08) ♡
• How to classify risk based on clinical and molecular modeling: integrating molecular markers in the risk assessment of myelodysplastic syndrome. (2023/12/08) ♡
• Minimal intensity conditioning strategies for bone marrow failure: is it time for "preventative" transplants? (2023/12/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clonal evolution in inherited marrow failure syndromes predicts disease progression. (2023/12/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myelodysplastic syndrome-like response after voriconazole treatment of systemic lupus erythematosus complicated with fungal infection: a case report. (2023/12/07) ♡
• Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms. (2023/12/05) ♡
• Lower-Risk Myelodysplastic Syndrome (MDS) Patients Exhibit Diminished Proteasome Proteolytic Activity and High Intracellular Reactive Oxygen Species (ROS) Levels. (2023/12/02) ♡
• Clinical significance of prognostic nutritional index in myelodysplastic syndrome. (2023/12/01) ♡
• ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cytogenetics and molecular genetics of myelodysplastic neoplasms. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. When to use which molecular prognostic scoring system in the management of patients with MDS? (2023/12/01) ♡
• Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan. (2023/12/01) ♡
• Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study. (2023/12/01) ♡
• Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities. (2023/11/30) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.